Tactile Medical's Strong Q1: 23% Revenue Growth & Positive EBITDA episode artwork

EPISODE · May 5, 2026 · 1 MIN

Tactile Medical's Strong Q1: 23% Revenue Growth & Positive EBITDA

from The Daily News Now! Business

Tactile Medical starts 2026 strong with 75.3M revenue, up 23% YoY, driven by 23% growth in lymphedema products and 22% in airway clearance. Gross margins rise to 76.5% and adjusted EBITDA turns positive at 3.7M. The company ends the quarter with 75M in cash, no debt, and completes the Lymphotech acquisition. Investors react positively to the beat on expectations, with full-year revenue guidance raised to 360-368M, implying 9-12% growth. Next-gen AffloVest gets FDA clearance and Lymphotech secures federal funding for advanced garments. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/56d95d7929de4d9e

NOW PLAYING

Tactile Medical's Strong Q1: 23% Revenue Growth & Positive EBITDA

0:00 1:49

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 1 minute long.

When was this The Daily News Now! Business episode published?

This episode was published on May 5, 2026.

What is this episode about?

Tactile Medical starts 2026 strong with 75.3M revenue, up 23% YoY, driven by 23% growth in lymphedema products and 22% in airway clearance. Gross margins rise to 76.5% and adjusted EBITDA turns positive at 3.7M. The company ends the quarter...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!